Spontaneous bleeding and poor bleeding response with extended half‐life factor IX products: A survey of select US haemophilia treatment centres

Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B

Jerry S. Powell, John Pasi, Margaret V. Ragni et al. · New England Journal of Medicine · 2013 · 347 citations · Full text

Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B

Claude Négrier, Karin Knobe, Andreas Tiede et al. · Blood · 2011 · 179 citations · Full text

Circulating and binding characteristics of wild-type factor IX and certain Gla domain mutants in vivo

Tong Gui, Hui-Feng Lin, Da-Yun Jin et al. · Blood · 2002 · 86 citations · Full text

Identification of the endothelial cell binding site for factor IX.

Wing-Fai Cheung, J van den Born, K. Kühn et al. · Proceedings of the National Academy of Sciences · 1996 · 85 citations

Factor Ix, Vascular Disease, Endothelial Cells +17

Abnormal hemostasis in a knock‐in mouse carrying a variant of factor IX with impaired binding to collagen type IV

Ting Gui, Heyu Ni, Peter L. Gross et al. · Journal of Thrombosis and Haemostasis · 2009 · 61 citations

Inflammation, Factor Ix, Knockout Mouse +9